Lucera Erick
Insider CIK 1697616 · AVEO Chief Financial Officer · BBLG Director · VLRX See Remarks · AITB Director · EDIT EVP, CHIEF FINANCIAL OFFICER · DYN Chief Financial Officer · SABS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-08-13 | 2026-08-17 | 1,797 | $26.28 | $47.2K | 119,766 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-08-13 | 2026-08-17 | 1,797 | $26.28 | $47.2K | 119,766 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-26 | 2,362 | $20.37 | $48.1K | 121,563 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-05-13 | 2026-05-14 | 1,448 | $18.36 | $26.6K | 123,925 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 5,727 | $18.64 | $106.8K | 125,373 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 105,000 | — | $0 | 105,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2026-02-12 | 2026-02-17 | 65,000 | — | $0 | 131,100 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-12-16 | 2025-12-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,500 | — | $0 | 1,500 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,500 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 2,000 | — | $0 | 2,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 2,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 2,250 | — | $0 | 2,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 2,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 3,750 | — | $0 | 3,750 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 3,750 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,000 | — | $0 | 1,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2025-03-31 | 2025-04-01 | 214,500 | — | $0 | 214,500 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2025-03-31 | 2025-04-01 | 66,100 | — | $0 | 66,100 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-03-26 | 2025-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2025-03-08 | 2025-03-27 | 70,000 | — | $0 | 70,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2025-03-08 | 2025-03-27 | 275,100 | — | $0 | 275,100 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2025-03-04 | 2025-03-05 | 4,109 | $1.71 | $7.0K | 112,720 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 20,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 45,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2024-08-14 | 2024-08-15 | 39,266 | $0.40 | $15.7K | 43,608 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 22,337 | $5.61 | $125.3K | 116,829 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-03-20 | 2024-03-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2024-03-02 | 2024-03-05 | 106,000 | — | $0 | 106,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2024-03-02 | 2024-03-05 | 25,966 | — | $0 | 139,166 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2024-03-02 | 2024-03-05 | 35,300 | — | $0 | 113,200 | SEC↗ |
| BBLG Bone Biologics Corp | A Award deriv | 2023-09-18 | 2023-09-20 | 85,763 | — | $0 | 85,763 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2023-05-17 | 2023-05-18 | 155,800 | — | $0 | 155,800 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2023-05-17 | 2023-05-18 | 77,900 | — | $0 | 77,900 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-04-03 | 2023-04-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-16 | 2023-03-20 | 2,000 | $6.82 | $13.6K | 4,342 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 218,800 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 50,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 100,000 | — | $0 | 0 | SEC↗ |
| BBLG Bone Biologics Corp | A Award deriv | 2022-08-23 | 2023-03-08 | 36,845 | — | $0 | 68,516 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2022-03-03 | 2022-03-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2022-02-15 | 2022-02-17 | 218,800 | — | $0 | 218,800 | SEC↗ |
| BBLG Bone Biologics Corp | A Award deriv | 2022-01-01 | 2022-02-28 | 8,722 | — | $0 | 31,671 | SEC↗ |
| BBLG Bone Biologics Corp | A Award deriv | 2021-10-26 | 2022-02-28 | 2,949 | — | $0 | 22,949 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2021-03-04 | 2021-03-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | M Exercise deriv | 2021-02-16 | 2021-03-03 | 1,171 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | M Exercise | 2021-02-16 | 2021-03-03 | 1,171 | $4.25 | $5.0K | 2,342 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2021-02-05 | 2021-04-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2020-01-06 | 2020-01-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| VLRX Valeritas Holdings Inc. | A Award deriv | 2019-03-07 | 2019-03-08 | 280,000 | — | $0 | 280,000 | SEC↗ |
| VLRX Valeritas Holdings Inc. | A Award deriv | 2018-11-19 | 2018-11-20 | 363,000 | — | $0 | 363,000 | SEC↗ |
| AITB AIT Therapeutics, Inc. | A Award deriv | 2018-08-13 | 2018-08-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AITB AIT Therapeutics, Inc. | M Exercise deriv | 2018-02-16 | 2018-04-30 | 1,171 | — | $0 | 0 | SEC↗ |
| AITB AIT Therapeutics, Inc. | P Buy deriv | 2018-02-16 | 2018-04-30 | 1,171 | $0.01 | $12 | 1,171 | SEC↗ |
| AITB AIT Therapeutics, Inc. | P Buy deriv | 2018-02-16 | 2018-04-30 | 1,171 | $0.01 | $12 | 1,171 | SEC↗ |
| AITB AIT Therapeutics, Inc. | M Exercise | 2018-02-16 | 2018-04-30 | 1,171 | $4.25 | $5.0K | 1,171 | SEC↗ |
| VLRX Valeritas Holdings Inc. | A Award deriv | 2018-02-13 | 2018-02-15 | 27,000 | — | $0 | 27,000 | SEC↗ |
| VLRX Valeritas Holdings Inc. | P Buy | 2017-05-22 | 2017-05-23 | 500 | $4.95 | $2.5K | 4,500 | SEC↗ |
| VLRX Valeritas Holdings Inc. | P Buy | 2017-05-22 | 2017-05-23 | 1,000 | $4.95 | $5.0K | 4,000 | SEC↗ |
| VLRX Valeritas Holdings Inc. | A Award deriv | 2017-03-23 | 2017-03-27 | 73,800 | — | $0 | 73,800 | SEC↗ |
| VLRX Valeritas Holdings Inc. | P Buy | 2017-03-23 | 2017-03-27 | 3,000 | $10.00 | $30.0K | 3,000 | SEC↗ |